... population[15], and standardised to a mean of 50 and standarddeviation of 10.Statistical AnalysesIntention-to-treat an alysis was undertaken. Baselinevalues ofthe scores for SF-36 were c arried ... design andthe editing ofthe manuscript. S-YG contributed to the study design. H-LW contributed to the interpretation ofthe data and the editing ofthe manuscript. All the authors read and approved ... resistanceexercise or both, on patient-reported health status and well-being in type 2diabetes mellitus: a randomised trial. Diabetologia: Clinical and Experimental Diabetesand Metabolism 20 10,...
... such as angina, acutemyocardial infarction (AMI), and cerebrovascular acci-dent (CVA), diabetes mellitus complications (microvas-cular, macrovascular, neuropathy), andthetype of treatment ... ofthe clinical assistance team ateach PCC was appointed as liaison officer between the PCC andthe technical group. Thestudy was approvedby the ethics committee ofthe Hospital Ramón y Cajal.Eligibility ... Pearson c 2 test was used for the qualita-tive variables, and McNemar’s test was used for paireddata. The change (mean end - mean start valu e) was calcu-lated in both diabetological education...
... data collected and participated in the design ofthe validation studyandthe development of the statistical plan. FP carried out the statistical analyses. Allauthors participated in the data ... multipletherapies (UKPDS49). JAMA 20 12, 28 1 :20 05-1999. 2. Chan JL, Abrahamson MJ: Pharmacological management of type 2diabetes mellitus: rationale for rational use of insulin. MayoClin Proc 20 03, ... characteristics ofthe male and female respond-ents are displayed in Table 1. Mean age in the total samplewas 59 ± 11 years, 54% were female, mean HbA1c was 6.8± 1.8 and participants had a mean diabetes...
... data collected and participated in the design ofthe validation studyandthe development of the statistical plan. FP carried out the statistical analyses. Allauthors participated in the data ... multipletherapies (UKPDS49). JAMA 20 12, 28 1 :20 05-1999. 2. Chan JL, Abrahamson MJ: Pharmacological management of type 2diabetes mellitus: rationale for rational use of insulin. MayoClin Proc 20 03, ... insulintreatment. To assess the appraisal of insulin therapy of persons withtype2 diabetes, we developed the insulin treatment appraisal scale (ITAS) and tested its reliability and validity in...
... out screening, randomization and examination ofthe patients, and performed part ofthe statisticalanalysis. All authors read, commented, and approved the final version of the manuscript.Competing ... indicate that lifestyle intervention is an importantpart ofthe management oftype2diabetes patients.Background Type 2diabetes can seriously affect patients’ health-related quality of life and ... Hospital.We thank laboratory technician Liselotte Spuur for laboratory assistance. Wethank the staff at the healthcare centre andthediabetes outpatient clinicfor participating in the study. Author...
... diabetes. Diabetes Care 1999 ;22 (3):403-8. 23 . Association AD. Standards of Medical Care in Diabetes. Diabetes Care 20 05 ;28 (suppl_1):S4-S36. 24 . Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. ... GADPH were: (forward) 5’-CAA GGT CAT CCC TGA CGT GAA-3’ and (reverse) 5’-CAG GTC CAC CAC TGA CAG GT-3’. The analysis of relative real time RT-PCR quantification was obtained using the threshold ... strength) study outcomes, analysis of covariance ofthe absolute change (week 16 – week 0) in each outcome variable was carried out adjusted for age, gender and years withdiabetes when appropriate....
... countries in Africa), and others were fromEgypt (2) , India, Pakistan and Saudi Arabia. A study in Kenya identified inadequate national guide-lines as a cause of insufficient knowledge and practice:" ;The ... infor-mation and learning needsof health care providers? And did it say anything about methods ofinformation needs assessment? Each article was then classified on the basis of: (1) whether information ... raiseawareness worldwide, and particularly among interna-tional agencies and major donors, ofthe urgent need tostrengthen political and financial commitment to meet the informationand learning...
... the data, and writing the article. RC contributed toanalyzing the data andthe interpretation ofthe results. RScontributed to analyzing and collecting the data. Allauthors have read and approved ... in a Thai sample withtype2 diabetes Phantipa Sakthong*1, Rungpetch Charoenvisuthiwongs 2 and Rossamalin Shabunthom3Address: 1Department of Pharmacy Practice, Faculty of Pharmaceutical ... Sciences, Chulalongkorn University, Bangkok, Thailand, 2 Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand and 3Sawangdandin Crown...
... children and adolescents withdiabetesand assessment of reliability and validity ofthe Persian version ofthe PedsQLTM 4.0 Generic Core Scales andthe PedsQLTM 3.0 Diabetes Module are the main ... self and parental perceptions. Pediatr Diabetes 20 11, 12( 1):34-40. 2. Pishdad GR: Low incidence oftype 1 diabetes in Iran. Diabetes Care 20 05, 28 (4): 927 - 928 . 3. Stevanović D, Lakić A, Damnjanović ... they have no competing interests. Author Contributions: PJ analyzed and wrote the manuscript and researched the data, EF researched the data, ZB wrote the manuscript and analyzed the data,...
... manuscript. All authors read anapproved the final manuscript.Acknowledgements The authors are grateful to the AOK Sachsen-Anhalt andthe AOK Rhein-land-Pfalz for support in sending out thestudy material ... patients anda challenge for primary care physicians. The aim of thiscross-sectional survey was to assess the impact of additional comorbidities on quality of life within a large sample of patients ... DH: Diabetes, Depres-sion and quality of life. Diabetes Care 20 04, 27 :1066-1070.3. Rubin RR, Peyrot M: Quality of life and diabetes. Diabetes MetabRes Rev 1999, 15 :20 5 -21 8. Health and Quality...
... scores,as represented by the RAND- 12 and SF- 12 [29 ,30]. The RAND-36 (or the related SF-36) has been frequentlyapplied in the assessment of health status in diabetes [20 ,22 -24 ]. The RAND-36 summary ... duration ofdiabetesof 20 .9 (SD 12. 4) years(median of 19.0 years), witha median age of diagnosis of 12. 0 years (Table 2) The majority of respondents were at a normal weight (47.9%) at diagnosis, ... 3in type2 diabetes. Med Decis Making 20 03, 23 :489-501. 26 . Maddigan SL, Feeny DH, Johnson JA: Construct validity of the RAND- 12 and Health Utilities Index Mark 2and Mark 3 in type 2 diabetes. ...
... Distribution-based methodsare based on mathematical calculations that involvestandard deviation, score range or Cronbach's alpha.Table 2: Distribution- and anchor-based MIDs for the Worry Scale of ... Management of hyperglycemia in type2 diabetes: a con-sensus algorithm for the initiation and adjustment of ther-apy. Diabetes Care 20 06, 29 :1963-19 72. 3. Cook MN, Girman CJ, Stein PP, Alexander ... L: The Fear of hypoglycemiascale. In Handbook of psychology and diabetes: a guide to psychologicalmeasurement anddiabetes research and practice Edited by: Bradley C.Langhorne: Hardwood Academia...
... October 20 09.17. Meadows KA, Abrams C, Sandbaek A: Adaptation oftheDiabetes HealthProfile (DHP-1) for use with patients withType2diabetes mellitus:psychometric evaluation and cross-cultural ... myocardial infarction and angina. Moreover, no information about the time of occurrence was available. The presence of both complications was associated with amoreimportantdecreasethanasingletypeofcomplication. Diabetes ... patients withtype2 diabetes. Diabetes Care 20 00, 23 :26 7 -27 2. 29 . Romon I, Fosse S, Eschwege E, Simon D, Weill A, Varroud-Vial M,Detournay B, Fagot-Campagna A: Prevalence of macrovascularcomplications...